|
gptkbp:instanceOf
|
gptkb:brand
contraceptive device
|
|
gptkbp:administeredBy
|
vaginal insertion
|
|
gptkbp:alsoKnownAs
|
gptkb:NuvaRing
|
|
gptkbp:approvalYear
|
2001
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:category
|
hormonal contraceptive
vaginal ring
|
|
gptkbp:contains
|
gptkb:etonogestrel
ethinylestradiol
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:duration
|
3 weeks
|
|
gptkbp:effect
|
over 99% with perfect use
|
|
gptkbp:followedBy
|
1 week ring-free
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nu ring
|
|
gptkbp:manufacturer
|
gptkb:Organon
|
|
gptkbp:marketedAs
|
gptkb:Merck_&_Co.
|
|
gptkbp:mechanismOfAction
|
inhibits ovulation
alters endometrial lining
thickens cervical mucus
|
|
gptkbp:notRecommendedFor
|
women over 35 who smoke
women with certain cancers
women with history of blood clots
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:reinsertAfter
|
1 week ring-free
|
|
gptkbp:removalTime
|
after 3 weeks
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
vaginal irritation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
birth control
|
|
gptkbp:website
|
https://www.nuvaring.com/
|
|
gptkbp:bfsParent
|
gptkb:Uranus_ring_system
gptkb:rings_of_Uranus
|
|
gptkbp:bfsLayer
|
7
|